▶ 調査レポート

世界の胆嚢がん治療薬市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Gallbladder Cancer Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の胆嚢がん治療薬市場規模・現状・予測(2021年-2027年) / Global Gallbladder Cancer Therapeutics Market Size, Status and Forecast 2021-2027 / QFJ1-5744資料のイメージです。• レポートコード:QFJ1-5744
• 出版社/出版日:QYResearch / 2021年6月
• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥425,100 (USD3,900)▷ お問い合わせ
  Multi User¥637,650 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、胆嚢がん治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(併用療法、単剤療法)、用途別市場規模(病院、医学研究所、診療所、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・胆嚢がん治療薬の市場動向
・企業の競争状況、市場シェア
・胆嚢がん治療薬の種類別市場規模と予測2016-2027(併用療法、単剤療法)
・胆嚢がん治療薬の用途別市場規模と予測2016-2027(病院、医学研究所、診療所、その他)
・胆嚢がん治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・胆嚢がん治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・胆嚢がん治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・胆嚢がん治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・胆嚢がん治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bristol-Myers Squibb Co.、Eli Lilly and Co.、F. Hoffmann-La Roche Ltd.、Pfizer Inc.、Sanofi.)
・結論

Rising incidence of cholelithiasis, chronic inflammation of the gallbladder, and gallbladder polyps are contributing to the prevalence of gallbladder cancer. This has resulted in a rise in demand for therapeutics for treating the condition.
Surgery is considered the primary treatment approach for gallbladder cancer, which involves the complete removal of the organ. However, the second line of treatment involves the use of radiation therapy along with chemotherapeutics. The rising availability of financial assistance programs is further helping patients in availing these high-cost treatments. With the increasing occurrence of these risk factors, the need for gallbladder cancer therapeutics will subsequently increase over the forecast period.

Market Analysis and Insights: Global Gallbladder Cancer Therapeutics Market
The global Gallbladder Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gallbladder Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gallbladder Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gallbladder Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gallbladder Cancer Therapeutics market.

Global Gallbladder Cancer Therapeutics Scope and Market Size
Gallbladder Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gallbladder Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Combination Therapy
Monotherapy

Segment by Application
Hospital
Medical Research Institute
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bristol-Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Pfizer Inc.
Sanofi.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gallbladder Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Combination Therapy
1.2.3 Monotherapy
1.3 Market by Application
1.3.1 Global Gallbladder Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Research Institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gallbladder Cancer Therapeutics Market Perspective (2016-2027)
2.2 Gallbladder Cancer Therapeutics Growth Trends by Regions
2.2.1 Gallbladder Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gallbladder Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gallbladder Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gallbladder Cancer Therapeutics Industry Dynamic
2.3.1 Gallbladder Cancer Therapeutics Market Trends
2.3.2 Gallbladder Cancer Therapeutics Market Drivers
2.3.3 Gallbladder Cancer Therapeutics Market Challenges
2.3.4 Gallbladder Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gallbladder Cancer Therapeutics Players by Revenue
3.1.1 Global Top Gallbladder Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gallbladder Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gallbladder Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gallbladder Cancer Therapeutics Revenue
3.4 Global Gallbladder Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Gallbladder Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gallbladder Cancer Therapeutics Revenue in 2020
3.5 Gallbladder Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Gallbladder Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Gallbladder Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gallbladder Cancer Therapeutics Breakdown Data by Type
4.1 Global Gallbladder Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gallbladder Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Gallbladder Cancer Therapeutics Breakdown Data by Application
5.1 Global Gallbladder Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gallbladder Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gallbladder Cancer Therapeutics Market Size (2016-2027)
6.2 North America Gallbladder Cancer Therapeutics Market Size by Type
6.2.1 North America Gallbladder Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gallbladder Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gallbladder Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Gallbladder Cancer Therapeutics Market Size by Application
6.3.1 North America Gallbladder Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gallbladder Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gallbladder Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Gallbladder Cancer Therapeutics Market Size by Country
6.4.1 North America Gallbladder Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gallbladder Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gallbladder Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Gallbladder Cancer Therapeutics Market Size by Type
7.2.1 Europe Gallbladder Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gallbladder Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gallbladder Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gallbladder Cancer Therapeutics Market Size by Application
7.3.1 Europe Gallbladder Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gallbladder Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gallbladder Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gallbladder Cancer Therapeutics Market Size by Country
7.4.1 Europe Gallbladder Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gallbladder Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gallbladder Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gallbladder Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Gallbladder Cancer Therapeutics Market Size by Type
9.2.1 Latin America Gallbladder Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gallbladder Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gallbladder Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gallbladder Cancer Therapeutics Market Size by Application
9.3.1 Latin America Gallbladder Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gallbladder Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gallbladder Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gallbladder Cancer Therapeutics Market Size by Country
9.4.1 Latin America Gallbladder Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gallbladder Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gallbladder Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bristol-Myers Squibb Co.
11.1.1 Bristol-Myers Squibb Co. Company Details
11.1.2 Bristol-Myers Squibb Co. Business Overview
11.1.3 Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Introduction
11.1.4 Bristol-Myers Squibb Co. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021)
11.1.5 Bristol-Myers Squibb Co. Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Details
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. Gallbladder Cancer Therapeutics Introduction
11.2.4 Eli Lilly and Co. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021)
11.2.5 Eli Lilly and Co. Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Details
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Gallbladder Cancer Therapeutics Introduction
11.4.4 Pfizer Inc. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021)
11.4.5 Pfizer Inc. Recent Development
11.5 Sanofi.
11.5.1 Sanofi. Company Details
11.5.2 Sanofi. Business Overview
11.5.3 Sanofi. Gallbladder Cancer Therapeutics Introduction
11.5.4 Sanofi. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021)
11.5.5 Sanofi. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gallbladder Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Combination Therapy
Table 3. Key Players of Monotherapy
Table 4. Global Gallbladder Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gallbladder Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gallbladder Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gallbladder Cancer Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Gallbladder Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gallbladder Cancer Therapeutics Market Share by Regions (2022-2027)
Table 10. Gallbladder Cancer Therapeutics Market Trends
Table 11. Gallbladder Cancer Therapeutics Market Drivers
Table 12. Gallbladder Cancer Therapeutics Market Challenges
Table 13. Gallbladder Cancer Therapeutics Market Restraints
Table 14. Global Gallbladder Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gallbladder Cancer Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Gallbladder Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gallbladder Cancer Therapeutics as of 2020)
Table 17. Ranking of Global Top Gallbladder Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gallbladder Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gallbladder Cancer Therapeutics Product Solution and Service
Table 21. Date of Enter into Gallbladder Cancer Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gallbladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gallbladder Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Gallbladder Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gallbladder Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gallbladder Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gallbladder Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Gallbladder Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gallbladder Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gallbladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gallbladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gallbladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gallbladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gallbladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gallbladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gallbladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gallbladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gallbladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gallbladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gallbladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gallbladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gallbladder Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gallbladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gallbladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gallbladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gallbladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gallbladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gallbladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gallbladder Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bristol-Myers Squibb Co. Company Details
Table 62. Bristol-Myers Squibb Co. Business Overview
Table 63. Bristol-Myers Squibb Co. Gallbladder Cancer Therapeutics Product
Table 64. Bristol-Myers Squibb Co. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Bristol-Myers Squibb Co. Recent Development
Table 66. Eli Lilly and Co. Company Details
Table 67. Eli Lilly and Co. Business Overview
Table 68. Eli Lilly and Co. Gallbladder Cancer Therapeutics Product
Table 69. Eli Lilly and Co. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Eli Lilly and Co. Recent Development
Table 71. F. Hoffmann-La Roche Ltd. Company Details
Table 72. F. Hoffmann-La Roche Ltd. Business Overview
Table 73. F. Hoffmann-La Roche Ltd. Gallbladder Cancer Therapeutics Product
Table 74. F. Hoffmann-La Roche Ltd. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. F. Hoffmann-La Roche Ltd. Recent Development
Table 76. Pfizer Inc. Company Details
Table 77. Pfizer Inc. Business Overview
Table 78. Pfizer Inc. Gallbladder Cancer Therapeutics Product
Table 79. Pfizer Inc. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Pfizer Inc. Recent Development
Table 81. Sanofi. Company Details
Table 82. Sanofi. Business Overview
Table 83. Sanofi. Gallbladder Cancer Therapeutics Product
Table 84. Sanofi. Revenue in Gallbladder Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Sanofi. Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gallbladder Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Combination Therapy Features
Figure 3. Monotherapy Features
Figure 4. Global Gallbladder Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Medical Research Institute Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Gallbladder Cancer Therapeutics Report Years Considered
Figure 10. Global Gallbladder Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Gallbladder Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Gallbladder Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Gallbladder Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Gallbladder Cancer Therapeutics Market Share by Players in 2020
Figure 15. Global Top Gallbladder Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gallbladder Cancer Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Gallbladder Cancer Therapeutics Revenue in 2020
Figure 17. Global Gallbladder Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Gallbladder Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Gallbladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Gallbladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Gallbladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gallbladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Gallbladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Gallbladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gallbladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Gallbladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Gallbladder Cancer Therapeutics Market Share by Region (2016-2027)
Figure 39. China Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gallbladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Gallbladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Gallbladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gallbladder Cancer Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Gallbladder Cancer Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Gallbladder Cancer Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Gallbladder Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Bristol-Myers Squibb Co. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2016-2021)
Figure 59. Eli Lilly and Co. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2016-2021)
Figure 60. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2016-2021)
Figure 61. Pfizer Inc. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2016-2021)
Figure 62. Sanofi. Revenue Growth Rate in Gallbladder Cancer Therapeutics Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed